Abstract
Latest advances in the study of motor neuron disease (MND) have pointed out some differences in the course of the illness; subgroups of patients with different survival experience have been identified. A review of studies based on survival analysis is reported in Table 1. It shows the 5-year survival variable from 10 to 50%. Few reports have been devoted to an extensive study of prognostic factors in MND[2, 14, 20, 23]. Age and clinical type at diagnosis are generally considered to influence the course of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. Berkson, Limitations of the application of four-fold table analysis to hospital data, Biometrics Bull., 2: 47–53 (1946).
J. T. Caroscio, W. F. Calhoum, and N. D. Yahr, Prognostic factors in motor neuron disease: a prospective study of longevity, in: F. Clifford Rose, ed., “Research Progress in Motor Neuron Disease,” Pitman, London, pp. 34–43 (1984).
A. Chió, F. Brignolio, M. Leone, P. Mortara, M. G. Rosso, A. Tribolo, and D. Schiffer, A survival analysis of 155 cases of progressive muscular atrophy, Acta Neurol.Scand., 72: 401–413 (1985).
M. Dalakas, G. Elder, and J. Sever, A 9-year follow-up study of patients with late postpoliomyelitis muscular atrophy (PPMA), Neurology, 35 (1): 108 (1985).
W. D. Dixon, M. B. Brown, L. Engleman, J. W. Frane, M. A. Hill, R. I. Jennrich, and J. D. Toporek, eds., “BMDP Statistical Software,” University of California Press, Los Angeles (1983).
L. Forsgren, B. G. L. Almay, G. Holmgren, and S. Wall, Epidemiology of motor neuron disease in Northern Sweden, Acta Neurol.Scand., 68: 20–29 (1983).
S. Gimenez-Roldán and A. Esteban, Esclerosis lateral amiotrófica familial. Critica de su clasificación y análisis de 14 familias de origen espagnol, Rev.Clin.Esp., 148: 167–173 (1978).
L. G. Gunnarsson and R. Palm, Motor neuron disease and heavy manual labor: an epidemiologic survey of Varmland county, Sweden, Neuroepid., 3: 195–206 (1984).
C. H. Hawkes, J. B. Cavanagh, S. Mowbray, and E. A. Paul, Familial motor neuron disease: report of a family with 5 post-mortem studies, in: “Research Progress in Motor Neuron Disease,” F. Clifford Rose, ed., Pitman, London, pp. 70–98 (1984).
K. Kondo and I. Hemmi, Clinical statistics in 515 fatal cases of motor neuron disease, Neuroepid., 3: 129–148 (1984).
O. Kristensen and B. Melgaard, Motor neuron disease, Prognosis and epidemiology, Acta Neurol.Scand., 56: 299–308 (1977).
S. M. Juergens, L. T. Kurland, H. Okazaki, and D. W. Mulder, ALS in Rochester, Minnesota, 1925-1977, Neurology, 30: 463–470 (1980).
P. Mortara, D. Bardelli, M. Leone, and D. Schiffer, Prognosis and clinical varieties of ALS disease, Ital.J.Neurol.Sei., 2: 237–242 (1981).
P. Mortara, A. Chio, M. G. Rosso, M. Leone, and D. Schiffer, Motor neuron disease in the province of Turin, Italy, 1966-1980, Survival analysis in an unselected population, J.Neurol.Sei., 66: 165–173 (1984).
D. W. Mulder, R. A. Rosenbaum, and D. Layton, Jr., Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis? Mayo Clinic Proc., 47: 756–761 (1972).
D. W. Mulder and F. M. Howard Jr., Patient resistance and prognosis in amyotrophic lateral sclerosis, Mayo Clinic Proc., 51: 537–541 (1976).
K. Murros and R. Fogelholm, Amyotrophic lateral sclerosis in Middle Finland: an epidemiological study, Acta Neurol.Scand., 67: 41–47 (1983).
F. H. Norris, Adult spinal motor neuron disease, in: “Handbook of Clinical Neurology,” P. J. Vinken and G. W. Bruyn, eds., vol.22, System Disorders and Atrophy, North-Holland, Amsterdam, pp. 1–56.
R. Peto, M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. MacPherson, J. Peto, and P. G. Smith, Design and analysis of randomized clinical trials requiring prolonged observation of each patient analysis and example, Brit.J.Cancer, 35: 1–39 (1977).
A. D. Rosen, Amyotrophic lateral sclerosis. Clinical features and prognosis, Arch.Neurol., 35: 638–642 (1978).
SAS user’s guide: basics, SAS Institute Inc., Cary, N.C. (1982).
R. L. Swank and T. J. Putnam, Amyotrophic lateral sclerosis and related conditions. A clinical analysis, Arch.Neurol.Psych., 49: 151–177 (1943).
Y. Uebayashi, Y. Yase, H. Tanaka, Y. Shimada, and Y. Toyokura, Prognosis of motor neuron disease in Japan, Neuroepid., 2: 243–256 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Schiffer, D., Brignolio, F., Chió, A., Leone, M., Rosso, M.G. (1987). A Study of Prognostic Factors in Motor Neuron Disease. In: Cosi, V., Kato, A.C., Parlette, W., Pinelli, P., Poloni, M. (eds) Amyotrophic Lateral Sclerosis. Advances in Experimental Medicine and Biology, vol 209. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5302-7_37
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5302-7_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5304-1
Online ISBN: 978-1-4684-5302-7
eBook Packages: Springer Book Archive